Alliance Pharma Share Discussion Threads

[baldrick1] 10/5/2024 10:57

Are you being a tonto blacky??;))

[seagreen] 10/5/2024 10:53

By the looks of last night Blacky you raided the cellar 8-)

You actually come up with the odd good sugestion but rather than go OTT and a bit tonto with your repetitive and wall papering of your latest trades 8-).......

Try and be a bit more subtle people will soon realise you make money and are worth following.

[blackhorse23] 10/5/2024 10:52

40p is coming

[seagreen] 10/5/2024 10:50

Have laid it down in the cellar for a few years and letting the new board mature like a fine wine 8-)

[baldrick1] 10/5/2024 10:41

When are you expecting to drink your chateau dU chasseur??;))

[seagreen] 10/5/2024 09:18

I very much doubt it.

[baldrick1] 10/5/2024 08:45

It's the end of the rally..It's now back to the 32-33p range.

[blackhorse23] 09/5/2024 22:21

New experience CEO in , group revenues up , profits up , debt down, free cash flow up , ALL GOOD. This accounting drama came from Deloitte who probably took some under table money delaying the account for shorters so they can buy back at good deal as it's happening

[tomzimerman] 09/5/2024 21:21

Personally I find the board quite balanced, apart from the obvious Individual there may be some light at the end but suspect ittl trade sideways until results are released so best not to fomo in tooooo deep

[justiceforthemany] 09/5/2024 21:18

Well the new CEO starts Monday so he can sign and date!

[jomojo76] 09/5/2024 21:07

On the Butterfield timing, CMA appeal is 7 months overdue and the CMA clearly stated that not being aware is no excuse. Wouldn't surprise me if Butterfield is disqualified from acting as a director so has the post of CEO in name only and can't sign off the accounts. So all a bit of an administrative mess affecting the audit and the search for a replacement taking longer than planned.

[justiceforthemany] 09/5/2024 18:01

Repeat - they need to sort out the mess with Deloitte and compromise is a must.
H1 is almost ending - these results are to December end. Forward guidance is all important.
Historically APH has traded at 15x P/E, now down to 8x.

[blackhorse23] 09/5/2024 17:59

Who have bought at dip ? Well done , likely go up towards 70p direction. Up on account publication it will be double

[seagreen] 09/5/2024 16:27

Sudden avalanche of negative bs

whif of burning opportunistic short spread betters




which is nice

[blackhorse23] 09/5/2024 16:25

Excellent day today , backing up again

[wad collector] 09/5/2024 16:11

Part of the uncertainty is that they haven't even suggested a new date; maybe they don't want the further ignominy of failing to deliver again. Butterfield departure is obviously highly suspicious in timing , hard to imagine that is not unconnected; though the comment that the January update is still accurate clearly has not reassured the market. Except Blackhorse , whose predictions have become more and more desperate and dubious.

[baldrick1] 09/5/2024 15:10

No traders are selling big time, I'm afraid.

[blackhorse23] 09/5/2024 14:51

Shorts are closing & buyers are back

[justiceforthemany] 09/5/2024 12:22

Common sense and compromise needs to prevail between Deloitte and the board. Or find an alternative.

[blackhorse23] 09/5/2024 11:42

Loads of 500k block buying, something brewing

[justiceforthemany] 09/5/2024 10:31

500K buys x 5
Dbay hold a significant stake here. Likely adding.

[blackhorse23] 09/5/2024 08:45

Last chance to buy below 30p

[eigthwonder] 09/5/2024 07:43

It’s been dodgy as a dodgy thing for years

[bones698] 09/5/2024 07:38

This looks awful tbh debts and not making money on 180m of sales with a pipeline of old drugs way past there sell by date na being suoerceeded. I suspect there are serious issues here hence delayed results.

Chart points to a possible disaster coming this way to. Be very carful listening to the Rampers they usually get it wrong.

For now I'll happily watch from the sidelines until we see results and see just what the issues are besides a very poor business plan